On this International Women's Day,  Lancet editors and the co-chairs of the Women and Cancer Commission discuss the burden of women’s cancer on society and reflect on the questions the Commission is trying to answer. 

Nick James discusses the key messages of the recent report from the STAMPEDE trial platform and the success of this platform in advancing the treatment of prostate cancer 

Helena Wang discusses The Lancet Commission on women's reproductive, maternal, newborn, child and adolescent health (RMNCAH) in China with author Professor Jie Qiao.

《柳叶刀》亚洲执行主编王辉对话《柳叶刀中国女性生殖、孕产妇、新生儿、儿童和青少年健康重大报告》共同主席乔杰院士。

Siobhan Quenby & Arri Coomarasamy discuss the key findings from The Lancet's new Series on miscarriage.

On the 50th anniversary of the Inverse Care Law, Professor Sir Muir Gray joins Gavin Cleaver to discuss the continuing importance of the ICL, and notions of value and quality in health care.

The Lancet's new Commission, Public Policy and Health in the Trump Era, looks back at the effects of the last four years on the health of the USA. One of the authors of the Commission, Mary Bassett (Harvard University) joins us to talk about the...

Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial.

Renee Salas, leader of the Lancet Countdown policy brief in the US, discusses the climate problems facing the US, the issues of the last four years, and the reasons to be optimistic about the future.

Universal health coverage (UHC) is a vital facet of healthcare across the world, and a new Global Burden of Disease paper seeks to measure its spread. The Lancet spoke with  author Rafael Lozano and linked Comment author Margaret Kruk about efforts to...

The Lancet Editor-in-Chief Richard Horton explains the current status of the Oxford and China COVID-19 vaccines, including an overview of current progress and the next steps for both.

The new Global Burden of Disease paper forecasts major alterations in worldwide population over the next few decades. We ask Kathleen O’Reilly, of LSHTM, how models are made and how you account for a changing world, and we speak with paper author Stein...

Professor Rosanna Peeling discusses the implications of seroprevalence results from recent COVID-19 antibody studies.

柳叶刀亚洲执行主编王辉跟曹彬教授关于2019冠状病毒感染住院患者临床发病过程和死亡危险因素的讨论

The Asia Executive Editor of The Lancet, Helena Hui Wang, chats with Bin Cao about clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China.